Clinical Trials Logo

Clinical Trial Summary

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms.

Prospective work based on the distribution of a dedicated questionnaire.


Clinical Trial Description

Patients with myeloproliferative neoplasms identified and followed in French Hospitals. Patients could be followed for polycythemia vera or essential thrombocythemia or primary myelofibrosis.

Distribution of the questionnaire to each patient with myeloproliferative neoplasm (treated or not) suffering from aquagenic pruritus.

Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04018209
Study type Observational
Source University Hospital, Brest
Contact Jean-Christophe IANOTTO
Phone +33298222523
Email jean-Christophe.ianotto@chu-brest.fr
Status Recruiting
Phase
Start date July 9, 2019
Completion date January 9, 2020